Solventum Corporation (SOLV) Earnings Dates & History
NYSE·Healthcare·Medical - Instruments & Supplies
$83.34
-2.88%
Mkt Cap $14.75B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $1.96B | $2.00B | +1.84% | $1.50 | $1.57 | +4.67% |
| Q4 2025 Nov 6, 2025 | $2.06B | $2.10B | +1.96% | $1.43 | $1.50 | +4.90% |
| Q3 2025 Aug 7, 2025 | $2.12B | $2.16B | +1.97% | $1.45 | $1.69 | +16.55% |
| Q2 2025 May 8, 2025 | $2.02B | $2.07B | +2.66% | $1.21 | $1.34 | +10.74% |
| Q1 2025 Feb 27, 2025 | $2.05B | $2.07B | +1.13% | $1.31 | $1.41 | +7.63% |
| Q4 2024 Nov 7, 2024 | $2.06B | $2.08B | +1.25% | $1.39 | $1.64 | +17.99% |
| Q3 2024 Aug 8, 2024 | $2.05B | $2.08B | +1.57% | $1.51 | $1.56 | +3.31% |
| Q2 2024 May 9, 2024 | $1.97B | $2.02B | +2.54% | $1.75 | $2.08 | +18.86% |
| Q4 2023 Dec 31, 2023 | — | $2.10B | — | — | $0.42 | — |
| Q3 2023 Sep 30, 2023 | — | $2.05B | — | — | $1.65 | — |
| Q2 2023 Jun 30, 2023 | — | $2.04B | — | — | $1.86 | — |
| Q1 2023 Mar 31, 2023 | — | $2.04B | — | — | $1.70 | — |
| Q4 2022 Dec 31, 2022 | — | $2.00B | — | — | $1.78 | — |
| Q3 2022 Sep 30, 2022 | — | $2.01B | — | — | $1.94 | — |
| Q2 2022 Jun 30, 2022 | — | $2.06B | — | — | $2.03 | — |
| Q1 2022 Mar 31, 2022 | — | $2.06B | — | — | $2.03 | — |